191 related articles for article (PubMed ID: 2427795)
21. Pristanic acid and phytanic acid in plasma from patients with a single peroxisomal enzyme deficiency.
ten Brink HJ; Wanders RJ; Stellaard F; Schutgens RB; Jakobs C
J Inherit Metab Dis; 1991; 14(3):345-8. PubMed ID: 1722861
[No Abstract] [Full Text] [Related]
22. Defective peroxisome biogenesis with a neuromuscular disorder resembling Werdnig-Hoffmann disease.
Baumgartner MR; Verhoeven NM; Jakobs C; Roels F; Espeel M; Martinez M; Rabier D; Wanders RJ; Saudubray JM
Neurology; 1998 Nov; 51(5):1427-32. PubMed ID: 9818873
[TBL] [Abstract][Full Text] [Related]
23. Phytanic acid oxidase activity in cultured skin fibroblasts. Diagnostic usefulness and limitations.
Skjeldal OH; Stokke O; Norseth J; Lie SO
Scand J Clin Lab Invest; 1986 May; 46(3):283-7. PubMed ID: 2424078
[TBL] [Abstract][Full Text] [Related]
24. Biochemical abnormalities in rhizomelic chondrodysplasia punctata.
Hoefler G; Hoefler S; Watkins PA; Chen WW; Moser A; Baldwin V; McGillivary B; Charrow J; Friedman JM; Rutledge L
J Pediatr; 1988 May; 112(5):726-33. PubMed ID: 2452243
[TBL] [Abstract][Full Text] [Related]
25. Zellweger syndrome in a preterm, small for gestational age infant.
Samsom JF; Jakobs C; van de Klei-van Moorsel J; Smit LM; Schutgens RB; Wanders RJ
J Inherit Metab Dis; 1992; 15(1):75-83. PubMed ID: 1583879
[TBL] [Abstract][Full Text] [Related]
26. Infantile phytanic acid storage disease, a possible variant of Refsum's disease: three cases, including ultrastructural studies of the liver.
Scotto JM; Hadchouel M; Odievre M; Laudat MH; Saudubray JM; Dulac O; Beucler I; Beaune P
J Inherit Metab Dis; 1982; 5(2):83-90. PubMed ID: 6188882
[TBL] [Abstract][Full Text] [Related]
27. Plasma and skin fibroblast C26 fatty acids in infantile Refsum's disease.
Poulos A; Sharp P
Neurology; 1984 Dec; 34(12):1606-9. PubMed ID: 6209596
[TBL] [Abstract][Full Text] [Related]
28. Refsum's disease: a peroxisomal disorder affecting phytanic acid alpha-oxidation.
Wierzbicki AS; Lloyd MD; Schofield CJ; Feher MD; Gibberd FB
J Neurochem; 2002 Mar; 80(5):727-35. PubMed ID: 11948235
[TBL] [Abstract][Full Text] [Related]
29. Long term survival of a patient with the cerebro-hepato-renal (Zellweger) syndrome.
Bleeker-Wagemakers EM; Oorthuys JW; Wanders RJ; Schutgens RB
Clin Genet; 1986 Feb; 29(2):160-4. PubMed ID: 3955868
[TBL] [Abstract][Full Text] [Related]
30. [Refsum's disease: evolution 35 years after diagnosis].
Marcaud V; Defontaines B; Jung P; Degos CF
Rev Neurol (Paris); 2002 Feb; 158(2):225-9. PubMed ID: 11965181
[TBL] [Abstract][Full Text] [Related]
31. Identification of 3 alpha,7 alpha,12 alpha-trihydroxy-5 beta-cholestan-26-oic acid, an intermediate in cholic acid synthesis, in the plasma of patients with infantile Refsum's disease.
Poulos A; Whiting MJ
J Inherit Metab Dis; 1985; 8(1):13-7. PubMed ID: 2581062
[TBL] [Abstract][Full Text] [Related]
32. Atypical refsum disease with pipecolic acidemia and abnormal catalase distribution.
Baumgartner MR; Jansen GA; Verhoeven NM; Mooyer PA; Jakobs C; Roels F; Espeel M; Fourmaintraux A; Bellet H; Wanders RJ; Saudubray JM
Ann Neurol; 2000 Jan; 47(1):109-13. PubMed ID: 10632109
[TBL] [Abstract][Full Text] [Related]
33. Multiple peroxisomal enzymatic deficiency disorders. A comparative biochemical and morphologic study of Zellweger cerebrohepatorenal syndrome and neonatal adrenoleukodystrophy.
Vamecq J; Draye JP; Van Hoof F; Misson JP; Evrard P; Verellen G; Eyssen HJ; Van Eldere J; Schutgens RB; Wanders RJ
Am J Pathol; 1986 Dec; 125(3):524-35. PubMed ID: 2879480
[TBL] [Abstract][Full Text] [Related]
34. Refsum's disease: nature of the enzyme defect.
Steinberg D; Herndon JH; Uhlendorf BW; Mize CE; Avigan J; Milne GW
Science; 1967 Jun; 156(3783):1740-2. PubMed ID: 4180573
[TBL] [Abstract][Full Text] [Related]
35. Phytanic acid alpha-oxidation: accumulation of 2-hydroxyphytanic acid and absence of 2-oxophytanic acid in plasma from patients with peroxisomal disorders.
ten Brink HJ; Schor DS; Kok RM; Poll-The BT; Wanders RJ; Jakobs C
J Lipid Res; 1992 Oct; 33(10):1449-57. PubMed ID: 1385561
[TBL] [Abstract][Full Text] [Related]
36. A new peroxisomal disorder: di- and trihydroxycholestanaemia due to a presumed trihydroxycholestanoyl-CoA oxidase deficiency.
Christensen E; Van Eldere J; Brandt NJ; Schutgens RB; Wanders RJ; Eyssen HJ
J Inherit Metab Dis; 1990; 13(3):363-6. PubMed ID: 2122101
[No Abstract] [Full Text] [Related]
37. Treatment of infantile phytanic acid storage disease: clinical, biochemical and ultrastructural findings in two children treated for 2 years.
Robertson EF; Poulos A; Sharp P; Manson J; Wise G; Jaunzems A; Carter R
Eur J Pediatr; 1988 Feb; 147(2):133-42. PubMed ID: 2452736
[TBL] [Abstract][Full Text] [Related]
38. Peroxisomes in fibroblasts from skin of Refsum's disease patients.
Beard ME; Sapirstein V; Kolodny EH; Holtzman E
J Histochem Cytochem; 1985 May; 33(5):480-4. PubMed ID: 2580885
[TBL] [Abstract][Full Text] [Related]
39. Mitochondrial oxidation of phytanic acid in human and monkey liver: implication that Refsum's disease is not a peroxisomal disorder.
Watkins PA; Mihalik SJ
Biochem Biophys Res Commun; 1990 Mar; 167(2):580-6. PubMed ID: 1690986
[TBL] [Abstract][Full Text] [Related]
40. Zellweger syndrome, retinal involvement.
Stanesu-Segal B; Evrard P
Metab Pediatr Syst Ophthalmol (1985); 1989; 12(4):96-9. PubMed ID: 2628705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
